RESEARCH STUDIES DIFFERENT TO CLINICAL TRIALS WITH DRUGS EVALUATED BY THE INSTITUTIONAL REVIEW BOARD OF UNIVERSITY HOSPITAL 'CENTRAL DE LA DEFENSA' IN 2011

被引：0
|
作者：
Garcia-Luque, A. [1 ]
Puerro-Vicente, M. [1 ]
Martinez-Terol, L. [1 ]
机构：
[1] Univ Hosp Cent Def, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 10 条
  • [1] THE IMPORTANCE OF A CENTRAL INSTITUTIONAL REVIEW BOARD IN MULTICENTER CLINICAL-TRIALS
    NEWMAN, RD
    GILSON, DC
    CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 265 - 265
  • [2] Phase i clinical trials evaluated by the research ethics committee of vall d'hebron university hospital in 2017 and 2018
    Leguizamo Martinez, L. M.
    Rodriguez, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S64 - S64
  • [3] Interlingual communication and interpreting at Virgen de la Arrixaca University Clinical Hospital (HCUVA). Research for action
    Sanchez-Pedreno Sanchez, Alba
    PANACEA-BOLETIN DE MEDICINA Y TRADUCCION, 2014, 15 (40): : 301 - 314
  • [4] Advancing Randomized Clinical Trials in Surgery: Role of Exception From Informed Consent, Central Institutional Review Board, and Bayesian Approaches
    Maiga, Amelia W.
    Snyder, Rebecca A.
    Kao, Lillian S.
    Raval, Mehul, V
    Patel, Mayur B.
    Blakely, Martin L.
    JOURNAL OF SURGICAL RESEARCH, 2025, 305 : A1 - A9
  • [5] Availability of post-trial access in clinical trials: a review of clinical trial protocols submitted to the research ethics board of the University of the Philippines Manila
    Jimenez, Edlyn B.
    Virtudazo, Jessa Mae P.
    Torres, Cristina E.
    Bernabe, Rosemarie dlC
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (11) : 1849 - 1855
  • [6] Reporting of Serious Adverse Events During Cancer Clinical Trials to the Institutional Review Board: An Evaluation by the Research on Adverse Drug Events And Reports (RADAR) Project
    Belknap, S. M.
    Georgopoulos, C. H.
    Lagman, J.
    Weitzman, S. A.
    Qualkenbush, L.
    Yarnold, P. R.
    Edwards, B. J.
    McKoy, J. M.
    Trifilio, S. M.
    West, D. P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12): : 1334 - 1340
  • [7] Developing Quality and Efficiency of Institutional Review Board Review Under a Human Research Protection Program at a Leading Hospital in Central Southern China: A Descriptive Analysis of the First Three Years
    Wang, Xiaomin
    Hahne, Jessica
    Li, Lun
    Khoshnood, Kaveh
    Yang, Guoping
    Yuan, Hong
    Liu, Xing
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2021, 16 (03) : 280 - 289
  • [8] SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer-Regulatory Process, Part II: The Role of the Institutional Review Board in Food and Drug Administration-Regulated Radiopharmaceutical Research
    Jeffers, Charlotte D.
    Hoffman, John M.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (02) : 97 - 102
  • [9] GILLES-DE-LA-TOURETTES SYNDROME - A REVIEW OF CLINICAL AND RESEARCH STUDIES AND CONSIDERATION OF FUTURE-DIRECTIONS FOR INVESTIGATION
    CAINE, ED
    ARCHIVES OF NEUROLOGY, 1985, 42 (04) : 393 - 397
  • [10] Variation in standards of research compensation and child assent practices: A comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials
    Kimberly, MB
    Hoehn, KS
    Feudtner, C
    Nelson, RM
    Schreiner, M
    PEDIATRICS, 2006, 117 (05) : 1706 - 1711
1